John LaMattina
Director/Board Member chez LIGAND PHARMACEUTICALS INCORPORATED
Fortune : 7 M $ au 31/03/2024
Profil
John L.
LaMattina is the founder of Alivio Therapeutics, Inc. He currently holds the following positions: Independent Director at Ligand Pharmaceuticals, Inc. since 2011, Independent Non-Executive Director at Puretech Health LLC since 2009, Director at Vedanta Biosciences, Inc. since 2012, Independent Non-Executive Director at PureTech Health Plc since 2009, Trustee at Boston College, Trustee at Worcester Polytechnic Institute, and Trustee at Terri Brodeur Breast Cancer Foundation.
In his former roles, Dr. LaMattina served as Chairman at Gelesis, Inc. from 2013 to 2019, Director at Neurogen Corp.
from 2008 to 2010, Director at Thermo Electron Corp.
from 2002 to 2006, Director at Human Genome Sciences, Inc. in 2012, Independent Director at Zafgen, Inc. from 2013 to 2020, Director at Decision Options LLC, Independent Director at Immunome, Inc. from 2017 to 2023, Director at Thermo Fisher Scientific, Inc. from 2002 to 2006, Director at Ziarco Pharma Ltd., Senior Vice President at Pfizer Inc. from 2004 to 2008, and President at Pfizer (St. Louis) from 2001 to 2007.
He also held the position of Senior Vice President-Worldwide Development at Pfizer Central Research from 1999 to 2003.
Dr. LaMattina completed his undergraduate degree at Boston College in 1971 and earned his doctorate from the University of New Hampshire in 1975.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PURETECH HEALTH PLC
0,46% | 14/02/2023 | 1 234 222 ( 0,46% ) | 3 M $ | 31/03/2024 |
| 09/06/2023 | 28 263 ( 0,16% ) | 2 M $ | 31/03/2024 | |
IMMUNOME, INC.
0,12% | 08/06/2023 | 66 953 ( 0,12% ) | 2 M $ | 31/03/2024 |
Postes actifs de John LaMattina
| Sociétés | Poste | Début |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 01/02/2011 |
| PURETECH HEALTH PLC | Director/Board Member | 01/01/2009 |
Alivio Therapeutics, Inc.
 Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | Founder | - |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Director/Board Member | 01/02/2012 |
| Terri Brodeur Breast Cancer Foundation | Director/Board Member | - |
| Worcester Polytechnic Institute | Director/Board Member | - |
| Boston College | Director/Board Member | - |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Director/Board Member | 01/01/2009 |
Anciens postes connus de John LaMattina
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOME, INC. | Director/Board Member | 02/10/2023 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de John LaMattina
| Boston College | Undergraduate Degree |
| University of New Hampshire | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| IMMUNOME, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| PURETECH HEALTH PLC | Health Technology |
| Entreprise privées | 13 |
|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Thermo Electron Corp.
 Thermo Electron Corp. Electronic Equipment/InstrumentsElectronic Technology Thermo Electron Corporation is a worldwide provider of analytical instruments, scientific equipment, services and software solutions for life science, drug discovery, clinical, environmental and industrial laboratories, as well as for use in a variety of manufacturing processes and in-the-field applications, including those associated with safety and homeland security | Electronic Technology |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
Decision Options LLC
 Decision Options LLC Investment ManagersFinance Decision Options LLC is a privately held, SEC-registered investment advisor and hedge fund manager headquartered in Groton, Connecticut. The firm was founded by Gill Eapen in 2001 to initially provide consultation and software for real estate valuation and portfolio management. They expanded the firm’s services to include investment advisory services for individual and institutional clients, thereafter. | Finance |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Finance |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
| Pfizer Central Research | |
| Terri Brodeur Breast Cancer Foundation | |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Health Technology |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Health Technology |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | Health Technology |
